Loxo: 2Q Earnings Snapshot
STAMFORD, Conn. (AP) _ Loxo Oncology Inc. (LOXO) on Thursday reported a loss of $11.7 million in its second quarter.
The Stamford, Connecticut-based company said it had a loss of 39 cents per share. Losses, adjusted for non-recurring gains, came to $1.68 per share.
The developer of cancer treatments posted revenue of $42.6 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $39.6 million.
Loxo shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.